Related Experiment Video
Updated: Mar 11, 2026

Determination of the Transport Rate of Xenobiotics and Nanomaterials Across the Placenta using the ex vivo Human Placental Perfusion Model
Published on: June 18, 2013
Transfer studies of polystyrene nanoparticles in the ex vivo human placenta perfusion model: key sources of artifacts
Stefanie Grafmueller1, Pius Manser2, Liliane Diener2
1Laboratory for Particles-Biology Interactions, Empa, St. Gallen, Switzerland; Perinatal Pharmacology, Department of Obstetrics, University Hospital Zurich, Zurich, Switzerland; Graduate School for Cellular and Biomedical Sciences, University of Berne, Berne, Switzerland.
Abstract:
Nanotechnology is a rapidly expanding and highly promising new technology with many different fields of application. Consequently, the investigation of engineered nanoparticles in biological systems is steadily increasing. Questions about the safety of such engineered nanoparticles are very important and the most critical subject with regard to the penetration of biological barriers allowing particle distribution throughout the human body. Such translocation studies are technically challenging and many issues have to be considered to obtain meaningful and comparable results. Here we report on the transfer of polystyrene nanoparticles across the human placenta using an ex vivo human placenta perfusion model. We provide an overview of several challenges that can potentially occur in any translocation study in relation to particle size distribution, functionalization and stability of labels. In conclusion, a careful assessment of nanoparticle properties in a physiologically relevant milieu is as challenging and important as the actual study of nanoparticle-cell interactions itself.

